Facebook Linkedin RSS Twitter Youtube
Home 2024

Metabolic disorders

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells
Insights

GLP1 and Harmine Therapy Reverses Diabetes in Mice by Regenerating Beta Cells

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism
Drug Discovery

Weight-Loss Drugs Could Exploit Fat Cells’ White-to-Beige Mechanism

Gene Variant Linked to Ancestry-Related Disparity in Diabetes Complications
Featured

Gene Variant Linked to Ancestry-Related Disparity in Diabetes Complications

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus
Bioprocessing

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment
Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Risk of Diabetes Caused by Antipsychotics Decreased by Pancreas Specific Dopamine Agonist
Drug Discovery

Risk of Diabetes Caused by Antipsychotics Decreased by Pancreas Specific Dopamine Agonist

Mussel-Inspired Polymer Helps Syntis Bio Deliver Drugs by Coating the Intestine
Drug Discovery

Mussel-Inspired Polymer Helps Syntis Bio Deliver Drugs by Coating the Intestine

“Obesity Paradox” of Cancer Immunotherapy Response Linked to Immune Checkpoint Protein on Macrophages
Cancer

“Obesity Paradox” of Cancer Immunotherapy Response Linked to Immune Checkpoint Protein on Macrophages

Mouse Metabolic Health Blueprint May Inform Human Studies
News

Mouse Metabolic Health Blueprint May Inform Human Studies

Icahn School of Medicine at Mount Sinai Awarded $21 million to Study Aging-Related Hormone
Drug Discovery

Icahn School of Medicine at Mount Sinai Awarded $21 million to Study Aging-Related Hormone

123...201Page 1 of 201
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.